Stay updated on AK104 in First-line Treatment of G/GEJ AdenoCa Clinical Trial
Sign up to get notified when there's something new on the AK104 in First-line Treatment of G/GEJ AdenoCa Clinical Trial page.

Latest updates to the AK104 in First-line Treatment of G/GEJ AdenoCa Clinical Trial page
- Check6 days agoChange DetectedA new revision entry (v3.5.5) was added to the history, replacing the previous revision (v3.5.4). This reflects an administrative update to the page's version history.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe latest version label on the page has been updated to Revision: v3.5.4, replacing the previous v3.5.3. This reflects a minor site maintenance update rather than changes to the study information.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page was updated to a newer ClinicalTrials.gov interface revision (v3.5.3 instead of v3.5.0), indicating a site/version update rather than a change to the clinical trial record details.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was deleted from the record history.SummaryDifference0.1%

- Check100 days agoChange DetectedRevision history now shows v3.4.3 added and v3.4.2 removed.SummaryDifference0.1%

- Check121 days agoChange DetectedThe record history now shows the addition of version v3.4.2 and the deletion of version v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to AK104 in First-line Treatment of G/GEJ AdenoCa Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104 in First-line Treatment of G/GEJ AdenoCa Clinical Trial page.